Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Donislecel - CellTrans

Next Previous
Drug Profile

Donislecel - CellTrans

Alternative Names: BB 11807; Lantidra; Purified allogeneic deceased donor pancreas derived islets of Langerhans - CellTrans

Latest Information Update: 04 Sep 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of Illinois at Chicago
  • Developer CellTrans
  • Class Antihyperglycaemics; Cell therapies
  • Mechanism of Action Pancreatic beta cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Type 1 diabetes mellitus

Most Recent Events

  • 29 Aug 2023 CellTrans and University of Illinois at Chicago complete an expanded-access programme for Type 1 diabetes mellitus (In adults, In the elderly) in USA (Intrahepatic) (NCT03791567)
  • 28 Jun 2023 Registered for Type 1 diabetes mellitus in USA (Intrahepatic, Infusion)
  • 28 Jun 2023 Efficacy and adverse events data from a pooled analysis of two clinical trials in Type 1 diabetes mellitus released by CellTrans

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top